Taizhou Pharmaceutical City Holding Group announced the bidding failure of the selection of the lead underwriter for the issuance of overseas bonds in 2025.

Taizhou Pharmaceutical City Holdings Group Co., Ltd. (hereinafter referred to as "Taizhou Pharmaceutical City Holdings Group") issued a notice of the failure of the selection of the lead underwriter for the issuance of overseas bonds in 2025.